SDC1 and plasma cell myeloma: Jung and collaborators demonstrated that a syndecan-1 juxtamembrane site, exposed upon shedding in endothelial and myeloma cells, binds both VEGF receptor 2 (VEGFR2) and very late antigen 4 (VLA-4).